Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Method for Mydriasis in Cataract Surgery
NCT02909140Terminated
- Sponsor
- Johns Hopkins University
- Start
- Sep 2016
- Primary completion
- Aug 2018
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
Randomised, single-blind trial of epinephrine nasal spray in cataract (3 arms), sponsored by Johns Hopkins University. Primary endpoint: Pupil Size Immediately Prior to Capsulorrhexis. Started Sep 2016; status: terminated.
02
Drugs
epinephrine nasal spray
03
Conditions
cataract
Beyond the preview
Go deeper on NCT02909140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02909140.